133 related articles for article (PubMed ID: 4357007)
1. [Herpesvirus hominis type 2 and Epstein-Barr virus antibodies in patients with cancer of the uterine cervix].
Vestergaard BF; Hornsleth A; Pedersen SN
Ugeskr Laeger; 1973 Jul; 135(27):1425-8. PubMed ID: 4357007
[No Abstract] [Full Text] [Related]
2. Occurrence of herpes- and adenovirus antibodies in patients with carcinoma of the cervix uteri. Measurement of antibodies to herpesvirus hominis (types 1 and 2), cytomegalovirus, EB-virus, and adenovirus.
Vestergaard BF; Hornsleth A; Pedersen SN
Cancer; 1972 Jul; 30(1):68-74. PubMed ID: 4339261
[No Abstract] [Full Text] [Related]
3. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
Aurelian L
Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
[No Abstract] [Full Text] [Related]
4. A population-based seroepidemiological study of cervical cancer.
Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
[TBL] [Abstract][Full Text] [Related]
5. Relation of type 2 Herpesvirus antibodies to cervical neoplasia. Barbados, West Indies, 1971.
Ory H; Conger B; Richart R; Barron B
Obstet Gynecol; 1974 Jun; 43(6):901-4. PubMed ID: 4364212
[No Abstract] [Full Text] [Related]
6. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
Najem SN; Barton IG; Al-Omar LS; Potter CW
Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
[TBL] [Abstract][Full Text] [Related]
7. [Herpes simplex virus type 2 antibodies in the husbans of women with cervical cancer].
Kunkel M; Oberender H; Rätz KH; Hofmann R; Gärtner L; Heise H
Z Gesamte Hyg; 1979 Aug; 25(8):597-9. PubMed ID: 228506
[No Abstract] [Full Text] [Related]
8. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda.
Adam E; Sharma SD; Zeigler O; Iwamoto K; Melnick JL; Levy AH; Rawls WE
J Natl Cancer Inst; 1972 Jan; 48(1):65-72. PubMed ID: 4347030
[No Abstract] [Full Text] [Related]
9. Antibodies to herpes simplex virus types 1 and 2: a comparative study using indirect haemagglutination in carcinoma of the cervix and in other malignant conditions.
Freymuth F; Morel C; Longson A; Tanguy M
Biomedicine; 1975 Sep; 23(7):271-5. PubMed ID: 182291
[TBL] [Abstract][Full Text] [Related]
10. Herpesvirus hominis: from latency to carcinogenesis?
Aurelian L
Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
[No Abstract] [Full Text] [Related]
11. [Formation of antibody to nucleocapsid and envelope of Herpes simplex virus hominis].
Doerr HW; Schmitz H; Petersen EE
Zentralbl Bakteriol Orig A; 1974; 227(1-4):348-54. PubMed ID: 4154610
[No Abstract] [Full Text] [Related]
12. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
Rawls WE; Adam E; Melnick JL
Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
[No Abstract] [Full Text] [Related]
13. [Prevalence of antibodies against herpes simplex virus, Epstein-Barr virus and cytomegalovirus in a group of patients after hemodialysis].
Resik S; Enamorado A; Tallo Y; Suárez C; Kourí V; Acosta B; García S
Rev Cubana Med Trop; 1999; 51(3):172-6. PubMed ID: 10887583
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 2 and carcinoma of cervix uteri.
Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
[No Abstract] [Full Text] [Related]
15. A seroepidemiological study of Epstein-Barr virus and other viral antigens in sarcoidosis.
Byrne EB; Evans AS; Fouts DW; Israel HL
Am J Epidemiol; 1973 May; 97(5):355-63. PubMed ID: 4349694
[No Abstract] [Full Text] [Related]
16. Epstein-Barr virus and heterophile antibodies in infectious mononucleosis.
Gotlieb-Stematsky T; Vonsover A; Modan M
Isr J Med Sci; 1974 Jul; 10(7):731-7. PubMed ID: 4368690
[No Abstract] [Full Text] [Related]
17. [Comparative study of serum HSV-2 antibody by immuno-enzyme slide method in high and low incidence areas of cancer of the uterine cervix (author's transl)].
Xiang JM
Zhonghua Zhong Liu Za Zhi; 1982 Feb; 4(1):23-5. PubMed ID: 6284465
[No Abstract] [Full Text] [Related]
18. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
[No Abstract] [Full Text] [Related]
19. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state.
Sener AG; Afsar I; Pinar E
J Virol Methods; 2009 Aug; 159(2):300-2. PubMed ID: 19406156
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between Herpes simplex virus type 2 and carcinoma of the uterine cervix].
Janda J
Cesk Gynekol; 1973 Jul; 38(6):454-60. PubMed ID: 4354419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
